Preferred Label : strontium ranelate;

MeSH note : an uncoupling agent containing strontium prevents bone loss by depressing bone resorption & maintaining bone formation in estrogen-deficient rats;

CISMeF synonym : 3-(3-cyano-4-carboxymethyl-5-carboxy-2-thienyl)-3-azapentanedioic distrontium salt; S 12911; S12911-0; S12911-2; S12911-5; protelos;

MeSH hyponym : S12911; S-12911;

Is substance : O;

UNII : 04NQ160FRU;

InChIKey : XXUZFRDUEGQHOV-UHFFFAOYSA-J;

Details


Main resources

You can consult :


http://www.has-sante.fr/portail/jcms/c_1751307/fr/les-medicaments-de-losteoporose
2023
false
true
false
France
French
bone density conservation agents
osteoporosis
treatment outcome
alendronic acid
alendronate
guidelines for drug use
zoledronic acid
administration, oral
risedronic acid
denosumab
Raloxifene Hydrochloride
strontium ranelate
strontium ranelate
teriparatide
teriparatide
spinal fractures
hip fractures
costs and cost analysis
bone density conservation agents
drug costs
bone density
risk
osteoporosis, postmenopausal
adrenal cortex hormones
osteoporosis
osteoporotic fractures
alendronic acid and colecalciferol
drugs, generic
infusions, intravenous
risedronic acid, calcium and colecalciferol, sequential
injections, subcutaneous
raloxifene
algorithms
Adrenocortical steroid therapy
corticosteroid therapy
Risedronic Acid
Denosumab
diphosphonates
imidazoles
organometallic compounds
thiophenes
Zoledronic Acid

---
http://www.prescrire.org/Fr/3/31/52988/0/NewsDetails.aspx
2017
false
false
false
France
French
journal article
strontium ranelate
drug, nos
gait, nos
strontium
pharmaceutical preparations
strontium, nos
organometallic compounds
thiophenes

---
http://www.prescrire.org/Fr/3/31/49173/0/2014/ArchiveNewsDetails.aspx?page=1
2014
false
false
false
journal article
french abstract
osteoporosis
strontium
osteoporosis
nursing
strontium ranelate

---
http://medecine-pharmacie.univ-rouen.fr/jsp/saisie/liste_fichiergw.jsp?OBJET=DOCUMENT&CODE=1260178086425&LANGUE=0
2014
false
false
false
false
France
critical appraisal or critical reading
osteoporosis, postmenopausal
strontium
osteoporotic fractures
spinal fractures
strontium ranelate

---
http://www.has-sante.fr/portail/jcms/c_1761869/fr/protelos
2014
false
false
false
France
French
evaluation of the transparency committee
administration, oral
strontium ranelate
strontium ranelate
bone density conservation agents
osteoporosis
osteoporosis, postmenopausal
bone density conservation agents
risk assessment
strontium ranelate
osteoporotic fractures
hip fractures
spinal fractures
guidelines for drug use
organometallic compounds
thiophenes
organometallic compounds
thiophenes

---
https://www.ema.europa.eu/medicines/human/EPAR/Protelos
2012
United Kingdom
English
French
syndication feed
treatment outcome
drug approval
drug labeling
administration, oral
powders
drug interactions
pregnancy
breast feeding
hip fractures
spinal fractures
aged
strontium ranelate
strontium ranelate
bone density conservation agents
bone density conservation agents
osteoporosis, postmenopausal
osteoporosis
drug evaluation
package leaflet
summary of product characteristics
organometallic compounds
thiophenes
organometallic compounds
thiophenes

---
https://www.ema.europa.eu/medicines/human/EPAR/Osseor
2012
United Kingdom
French
English
syndication feed
organometallic compounds
organometallic compounds
thiophenes
osteoporosis, postmenopausal
thiophenes
treatment outcome
drug evaluation
drug approval
drug labeling
hip fractures
spinal fractures
bone density conservation agents
bone density conservation agents
drug interactions
strontium ranelate
strontium ranelate
strontium ranelate
organometallic compounds
thiophenes
osteoporosis
drug evaluation
package leaflet
summary of product characteristics

---
http://www.has-sante.fr/portail/jcms/c_1096125/protelos-ranelate-de-strontium-anti-osteoporotique
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-06/protelos_-_ct-8814.pdf
2011
France
French
drug hypersensitivity syndrome
evaluation of the transparency committee
guidelines for drug use
administration, oral
strontium ranelate
osteoporosis, postmenopausal
fractures, bone
strontium ranelate
insurance, health, reimbursement
bone density conservation agents
thiophenes
organometallic compounds
treatment outcome
organometallic compounds
thiophenes
bone density conservation agents
strontium ranelate
venous thromboembolism
memory disorders
seizures
consciousness disorders
pulmonary embolism
product surveillance, postmarketing
eosinophilia

---
http://www.has-sante.fr/portail/jcms/c_1060122/protelos
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-06/protelos_-_ct-8814.pdf
2011
France
French
evaluation of the transparency committee
organometallic compounds
organometallic compounds
thiophenes
thiophenes
osteoporosis, postmenopausal
strontium ranelate
administration, oral
insurance, health, reimbursement
strontium ranelate
bone density conservation agents
treatment outcome
strontium ranelate
spinal fractures
hip fractures

---
http://www.cochrane.org/fr/CD005326
2008
false
true
false
United Kingdom
France
osteoporosis, postmenopausal
treatment outcome
review of literature
french abstract
osteoporosis, postmenopausal
strontium ranelate
strontium

---
https://rmlg.uliege.be/article/1676
2007
Belgium
French
strontium ranelate
organometallic compounds
thiophenes
bone density conservation agents
aged
belgium
treatment outcome
fractures, bone
strontium ranelate
osteoporosis, postmenopausal
organometallic compounds
thiophenes
journal article
drug information

---
Nous contacter.
17/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.